MIMI HILL: Open Payments
NPI 1699365106 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 44 payments from 13 companies in 2025. Trend: 2023 $1,347 · 2024 $1,485 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 5 | $295 |
| GENZYME CORPORATION | 9 | $204 |
| ABBVIE INC. | 12 | $169 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| PFIZER INC. | 3 | $52 |
| Lilly USA, LLC | 2 | $42 |
| ConvaTec Inc. | 1 | $40 |
| Dexcom, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $25 |
Products named: DAXXIFY, DUPIXENT, BOTOX, COSENTYX, CIBINQO, SKYRIZI, INNOVAMATRIX AC, Dexcom G6 Transmitter.
Industry payments across AR — which companies pay providers there.
